Home
Forums
New posts
Contact Us
What's new
New posts
New media
New media comments
Latest activity
Media
New media
New comments
Search media
Search All
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Contact Us
Menu
Log in
Register
Install the app
Install
Forums
Really good
Life
Senate Inquiry On Drug Prices Echoes Landmark Hearings Held 60 Years Ago
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="cheryl" data-source="post: 892" data-attributes="member: 1"><p><a href="https://www.npr.org/sections/health-shots/2019/02/22/696967037/senate-inquiry-on-drug-prices-echoes-landmark-hearings-held-60-years-ago" target="_blank"><strong>Senate Inquiry On Drug Prices Echoes Landmark Hearings Held 60 Years Ago - NPR</strong></a></p><p></p><p>On Tuesday, Kenneth Frazier, CEO of pharmaceutical giant Merck, is set to face senators who say drug costs are "sky-high" and "out of control."</p><p> </p><p>But Frazier doesn't need new talking points. Sixty years ago, a different panel of senators grilled a different Merck boss about the same problem.</p><p> </p><p>To a striking degree, the subjects likely to surface Tuesday — high drug prices and profits, limited price transparency, aggressive marketing, alleged patent abuse and mediocre "me too" drugs — are identical to the issues senators investigated decades ago, historical transcripts show.</p></blockquote><p></p>
[QUOTE="cheryl, post: 892, member: 1"] [URL='https://www.npr.org/sections/health-shots/2019/02/22/696967037/senate-inquiry-on-drug-prices-echoes-landmark-hearings-held-60-years-ago'][B]Senate Inquiry On Drug Prices Echoes Landmark Hearings Held 60 Years Ago - NPR[/B][/URL] On Tuesday, Kenneth Frazier, CEO of pharmaceutical giant Merck, is set to face senators who say drug costs are "sky-high" and "out of control." But Frazier doesn't need new talking points. Sixty years ago, a different panel of senators grilled a different Merck boss about the same problem. To a striking degree, the subjects likely to surface Tuesday — high drug prices and profits, limited price transparency, aggressive marketing, alleged patent abuse and mediocre "me too" drugs — are identical to the issues senators investigated decades ago, historical transcripts show. [/QUOTE]
Verification
Post reply
Forums
Really good
Life
Senate Inquiry On Drug Prices Echoes Landmark Hearings Held 60 Years Ago
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top